Accounts Payable, Accrued Expenses and Other

9 Months Ended

Sep. 30, 2019

Payables And Accruals [Abstract]

Accounts Payable, Accrued Expenses and Other

7. Accounts Payable, Accrued Expenses and Other

Accounts payable, accrued expenses and other as of September 30, 2019 and December 31, 2018 consisted of the following:

(in thousands)	September 30, 2019		December 31, 2018
Accounts payable	$	710	$	1,034
Accrued goods and services		1,399		2,082
Accrued clinical trial costs		684		1,683
Accrued drug purchase costs		371		4,245
Accrued payroll and related benefits		—		2,315
Accrued restructuring expenses		122		921
Income taxes payable		83		83
Deferred tax incentives		1,314		1,314
Total accounts payable, accrued expenses and other	$	4,683	$	13,677